Journal article 229 views 36 downloads
Alzheimer's diagnosis beyond cerebrospinal fluid: Probe-Free Detection of Tau Proteins using MXene based redox systems and molecularly imprinted polymers
Biosensors and Bioelectronics: X, Volume: 20, Start page: 100513
Swansea University Authors: Arjun Ajith Mohan , Tom Dunlop , Georgeta Vulpe, Sanjiv Sharma
-
PDF | Version of Record
© 2024 The Author(s). This is an open access article under the CC BY license.
Download (5.44MB)
DOI (Published version): 10.1016/j.biosx.2024.100513
Abstract
Phosphorylated Tau proteins are promising biomarkers for the diagnosis and prognosis of Alzheimer's disease. This study presents a novel voltametric sensor using a vanadium MXene polydopamine (VxPDA) redox active composite and a Tau-441-specific polyaniline molecularly imprinted polymer (PANI M...
Published in: | Biosensors and Bioelectronics: X |
---|---|
ISSN: | 2590-1370 |
Published: |
Elsevier BV
2024
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa66925 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2024-07-02T14:52:41Z |
---|---|
last_indexed |
2024-07-02T14:52:41Z |
id |
cronfa66925 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>66925</id><entry>2024-07-02</entry><title>Alzheimer's diagnosis beyond cerebrospinal fluid: Probe-Free Detection of Tau Proteins using MXene based redox systems and molecularly imprinted polymers</title><swanseaauthors><author><sid>852f42c2a4dd3f47711475ca17030bf9</sid><ORCID>0000-0001-6781-2108</ORCID><firstname>Arjun</firstname><surname>Ajith Mohan</surname><name>Arjun Ajith Mohan</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>809395460ab1e6b53a906b136d919c41</sid><ORCID>0000-0002-5851-8713</ORCID><firstname>Tom</firstname><surname>Dunlop</surname><name>Tom Dunlop</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>d1d5815c60d63534a10a81489255c681</sid><firstname>Georgeta</firstname><surname>Vulpe</surname><name>Georgeta Vulpe</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b6b7506358522f607b171ec9c94757b7</sid><ORCID>0000-0003-3828-737X</ORCID><firstname>Sanjiv</firstname><surname>Sharma</surname><name>Sanjiv Sharma</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2024-07-02</date><deptcode>EAAS</deptcode><abstract>Phosphorylated Tau proteins are promising biomarkers for the diagnosis and prognosis of Alzheimer's disease. This study presents a novel voltametric sensor using a vanadium MXene polydopamine (VxPDA) redox active composite and a Tau-441-specific polyaniline molecularly imprinted polymer (PANI MIP) for the sensitive detection of Tau-441 in interstitial fluid (ISF) and plasma. The VxPDA/PANI MIP sensor demonstrates a broad detection range of 5 fg/mL to 5 ng/mL (122 aM/L to 122 pM/L) in ISF without the use of redox mediators, with a lower limit of detection (LOD) of 2.3 fg/mL (60 aM/L). Furthermore, a handheld device utilizing this technology successfully detects Tau-441 in artificial serum with high sensitivity (5 fg/mL to 150 fg/mL (122 aM/L to 366 aM/L)) and specificity within a clinically relevant range. The rapid detection time (~32 minutes) and low cost (~£20/device) of this sensor highlight its potential for minimally invasive, early AD diagnosis in clinical settings. This advancement aims to facilitate a transition away from invasive cerebrospinal fluid (CSF)-based diagnostic techniques for AD.</abstract><type>Journal Article</type><journal>Biosensors and Bioelectronics: X</journal><volume>20</volume><journalNumber/><paginationStart>100513</paginationStart><paginationEnd/><publisher>Elsevier BV</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>2590-1370</issnPrint><issnElectronic/><keywords>Alzheimer&apos; disease, Tau protein, Biomarker</keywords><publishedDay>1</publishedDay><publishedMonth>10</publishedMonth><publishedYear>2024</publishedYear><publishedDate>2024-10-01</publishedDate><doi>10.1016/j.biosx.2024.100513</doi><url/><notes/><college>COLLEGE NANME</college><department>Engineering and Applied Sciences School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>EAAS</DepartmentCode><institution>Swansea University</institution><apcterm>External research funder(s) paid the OA fee (includes OA grants disbursed by the Library)</apcterm><funders>The authors thank the MRC-AMED UK-Japan project (Multi-analyte prognostic and diagnostic screening in blood and skin for Alzheimer's disease, MR/X02153X/1) for their support. We also thank AIM providing SEM, EDS, and XPS facilities. AIM is funded in part by the EPSRC (EP/M028267/1), the European Regional Development Fund through the Welsh Government (80708) and the Welsh Government's Ser Cymru Program.</funders><projectreference/><lastEdited>2024-07-25T13:28:15.3350919</lastEdited><Created>2024-07-02T15:38:59.2727799</Created><path><level id="1">Faculty of Science and Engineering</level><level id="2">School of Engineering and Applied Sciences - Biomedical Engineering</level></path><authors><author><firstname>Arjun</firstname><surname>Ajith Mohan</surname><orcid>0000-0001-6781-2108</orcid><order>1</order></author><author><firstname>Sudhaunsh</firstname><surname>Deshpande</surname><order>2</order></author><author><firstname>Tom</firstname><surname>Dunlop</surname><orcid>0000-0002-5851-8713</orcid><order>3</order></author><author><firstname>Beth</firstname><surname>Norman</surname><order>4</order></author><author><firstname>Daniela</firstname><surname>Oliviera</surname><order>5</order></author><author><firstname>Georgeta</firstname><surname>Vulpe</surname><order>6</order></author><author><firstname>Felismina</firstname><surname>Moreira</surname><orcid>0000-0003-4237-8952</orcid><order>7</order></author><author><firstname>Sanjiv</firstname><surname>Sharma</surname><orcid>0000-0003-3828-737X</orcid><order>8</order></author></authors><documents><document><filename>66925__30982__0abfbc8f431845d1b0a758fe9ac51d14.pdf</filename><originalFilename>66925.VoR.pdf</originalFilename><uploaded>2024-07-25T13:25:23.0978146</uploaded><type>Output</type><contentLength>5699948</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© 2024 The Author(s). This is an open access article under the CC BY license.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs><OutputDur><Id>261</Id><DataControllerName>Sanjiv Sharma</DataControllerName><DataControllerEmail>sanjiv.sharma@swansea.ac.uk</DataControllerEmail><IsDataAvailableOnline>false</IsDataAvailableOnline><DataNotAvailableOnlineReasonId>4</DataNotAvailableOnlineReasonId><IsDurRestrictions xsi:nil="true"/><DurRestrictionReasonId xsi:nil="true"/><DurEmbargoDate xsi:nil="true"/></OutputDur></OutputDurs></rfc1807> |
spelling |
v2 66925 2024-07-02 Alzheimer's diagnosis beyond cerebrospinal fluid: Probe-Free Detection of Tau Proteins using MXene based redox systems and molecularly imprinted polymers 852f42c2a4dd3f47711475ca17030bf9 0000-0001-6781-2108 Arjun Ajith Mohan Arjun Ajith Mohan true false 809395460ab1e6b53a906b136d919c41 0000-0002-5851-8713 Tom Dunlop Tom Dunlop true false d1d5815c60d63534a10a81489255c681 Georgeta Vulpe Georgeta Vulpe true false b6b7506358522f607b171ec9c94757b7 0000-0003-3828-737X Sanjiv Sharma Sanjiv Sharma true false 2024-07-02 EAAS Phosphorylated Tau proteins are promising biomarkers for the diagnosis and prognosis of Alzheimer's disease. This study presents a novel voltametric sensor using a vanadium MXene polydopamine (VxPDA) redox active composite and a Tau-441-specific polyaniline molecularly imprinted polymer (PANI MIP) for the sensitive detection of Tau-441 in interstitial fluid (ISF) and plasma. The VxPDA/PANI MIP sensor demonstrates a broad detection range of 5 fg/mL to 5 ng/mL (122 aM/L to 122 pM/L) in ISF without the use of redox mediators, with a lower limit of detection (LOD) of 2.3 fg/mL (60 aM/L). Furthermore, a handheld device utilizing this technology successfully detects Tau-441 in artificial serum with high sensitivity (5 fg/mL to 150 fg/mL (122 aM/L to 366 aM/L)) and specificity within a clinically relevant range. The rapid detection time (~32 minutes) and low cost (~£20/device) of this sensor highlight its potential for minimally invasive, early AD diagnosis in clinical settings. This advancement aims to facilitate a transition away from invasive cerebrospinal fluid (CSF)-based diagnostic techniques for AD. Journal Article Biosensors and Bioelectronics: X 20 100513 Elsevier BV 2590-1370 Alzheimer' disease, Tau protein, Biomarker 1 10 2024 2024-10-01 10.1016/j.biosx.2024.100513 COLLEGE NANME Engineering and Applied Sciences School COLLEGE CODE EAAS Swansea University External research funder(s) paid the OA fee (includes OA grants disbursed by the Library) The authors thank the MRC-AMED UK-Japan project (Multi-analyte prognostic and diagnostic screening in blood and skin for Alzheimer's disease, MR/X02153X/1) for their support. We also thank AIM providing SEM, EDS, and XPS facilities. AIM is funded in part by the EPSRC (EP/M028267/1), the European Regional Development Fund through the Welsh Government (80708) and the Welsh Government's Ser Cymru Program. 2024-07-25T13:28:15.3350919 2024-07-02T15:38:59.2727799 Faculty of Science and Engineering School of Engineering and Applied Sciences - Biomedical Engineering Arjun Ajith Mohan 0000-0001-6781-2108 1 Sudhaunsh Deshpande 2 Tom Dunlop 0000-0002-5851-8713 3 Beth Norman 4 Daniela Oliviera 5 Georgeta Vulpe 6 Felismina Moreira 0000-0003-4237-8952 7 Sanjiv Sharma 0000-0003-3828-737X 8 66925__30982__0abfbc8f431845d1b0a758fe9ac51d14.pdf 66925.VoR.pdf 2024-07-25T13:25:23.0978146 Output 5699948 application/pdf Version of Record true © 2024 The Author(s). This is an open access article under the CC BY license. true eng http://creativecommons.org/licenses/by/4.0/ 261 Sanjiv Sharma sanjiv.sharma@swansea.ac.uk false 4 |
title |
Alzheimer's diagnosis beyond cerebrospinal fluid: Probe-Free Detection of Tau Proteins using MXene based redox systems and molecularly imprinted polymers |
spellingShingle |
Alzheimer's diagnosis beyond cerebrospinal fluid: Probe-Free Detection of Tau Proteins using MXene based redox systems and molecularly imprinted polymers Arjun Ajith Mohan Tom Dunlop Georgeta Vulpe Sanjiv Sharma |
title_short |
Alzheimer's diagnosis beyond cerebrospinal fluid: Probe-Free Detection of Tau Proteins using MXene based redox systems and molecularly imprinted polymers |
title_full |
Alzheimer's diagnosis beyond cerebrospinal fluid: Probe-Free Detection of Tau Proteins using MXene based redox systems and molecularly imprinted polymers |
title_fullStr |
Alzheimer's diagnosis beyond cerebrospinal fluid: Probe-Free Detection of Tau Proteins using MXene based redox systems and molecularly imprinted polymers |
title_full_unstemmed |
Alzheimer's diagnosis beyond cerebrospinal fluid: Probe-Free Detection of Tau Proteins using MXene based redox systems and molecularly imprinted polymers |
title_sort |
Alzheimer's diagnosis beyond cerebrospinal fluid: Probe-Free Detection of Tau Proteins using MXene based redox systems and molecularly imprinted polymers |
author_id_str_mv |
852f42c2a4dd3f47711475ca17030bf9 809395460ab1e6b53a906b136d919c41 d1d5815c60d63534a10a81489255c681 b6b7506358522f607b171ec9c94757b7 |
author_id_fullname_str_mv |
852f42c2a4dd3f47711475ca17030bf9_***_Arjun Ajith Mohan 809395460ab1e6b53a906b136d919c41_***_Tom Dunlop d1d5815c60d63534a10a81489255c681_***_Georgeta Vulpe b6b7506358522f607b171ec9c94757b7_***_Sanjiv Sharma |
author |
Arjun Ajith Mohan Tom Dunlop Georgeta Vulpe Sanjiv Sharma |
author2 |
Arjun Ajith Mohan Sudhaunsh Deshpande Tom Dunlop Beth Norman Daniela Oliviera Georgeta Vulpe Felismina Moreira Sanjiv Sharma |
format |
Journal article |
container_title |
Biosensors and Bioelectronics: X |
container_volume |
20 |
container_start_page |
100513 |
publishDate |
2024 |
institution |
Swansea University |
issn |
2590-1370 |
doi_str_mv |
10.1016/j.biosx.2024.100513 |
publisher |
Elsevier BV |
college_str |
Faculty of Science and Engineering |
hierarchytype |
|
hierarchy_top_id |
facultyofscienceandengineering |
hierarchy_top_title |
Faculty of Science and Engineering |
hierarchy_parent_id |
facultyofscienceandengineering |
hierarchy_parent_title |
Faculty of Science and Engineering |
department_str |
School of Engineering and Applied Sciences - Biomedical Engineering{{{_:::_}}}Faculty of Science and Engineering{{{_:::_}}}School of Engineering and Applied Sciences - Biomedical Engineering |
document_store_str |
1 |
active_str |
0 |
description |
Phosphorylated Tau proteins are promising biomarkers for the diagnosis and prognosis of Alzheimer's disease. This study presents a novel voltametric sensor using a vanadium MXene polydopamine (VxPDA) redox active composite and a Tau-441-specific polyaniline molecularly imprinted polymer (PANI MIP) for the sensitive detection of Tau-441 in interstitial fluid (ISF) and plasma. The VxPDA/PANI MIP sensor demonstrates a broad detection range of 5 fg/mL to 5 ng/mL (122 aM/L to 122 pM/L) in ISF without the use of redox mediators, with a lower limit of detection (LOD) of 2.3 fg/mL (60 aM/L). Furthermore, a handheld device utilizing this technology successfully detects Tau-441 in artificial serum with high sensitivity (5 fg/mL to 150 fg/mL (122 aM/L to 366 aM/L)) and specificity within a clinically relevant range. The rapid detection time (~32 minutes) and low cost (~£20/device) of this sensor highlight its potential for minimally invasive, early AD diagnosis in clinical settings. This advancement aims to facilitate a transition away from invasive cerebrospinal fluid (CSF)-based diagnostic techniques for AD. |
published_date |
2024-10-01T13:28:14Z |
_version_ |
1805554018864332800 |
score |
11.035655 |